1. a) Jacques V, Desreux JF. Synthesis of MRI Contrast Agents II. Macrocyclic Ligands. In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; Merbach AE, Toth E (Eds.), John Wiley and Sons: New York, NY; 2001. p 157-191; b) Stasiuk GJ, Long NJ. Chem Commun; 2013;49:2732; c) Hermanson GT. Bioconjugate Techniques Academic press; 1996; d) Lattuada L, Barge A, Cravotto G, Giovenzana GB, Tei L. Chem. Soc. Rev.; 2011, 40, 3019; e) Liu S. Adv. Drug Delivery Rev.; 2008, 60, 1347; f) Minazzi P, Lattuada L, Menegotto IG, Giovenzana GB. Org. Biomol. Chem. 2014, 12, 6915.
2. a) Wadas TJ, Wong e. H, Weisman GR, Anderson CJ. Chem. Rev. 2010, 110, 3019
3. b) Kovacs Z, De Leon-Rodriguez LM. Mini Rev. Org. Chem. 2007, 72, 281.
4. Surface Functionalization Using Catalyst-Free Azide−Alkyne Cycloaddition
5. a) Debets MF, Van Verkel, SS, Dommerhot J, Dirks ATJ, Rutjes FPJT, Van Delft FL. Acc. Chem. Res.2011; 44, 9, 805-815; b) Suchy M, Bartha R, Hudson RHE. RSC Adv.; 2013, 3, 3249.